View of SYNTHESIS AND CHARACTERIZATION OF PHARMACEUTICAL INTERMEDIATES

(1)

ACCENT JOURNAL OF ECONOMICS ECOLOGY & ENGINEERING

Peer Reviewed and Refereed Journal ISSN NO. 2456-1037 IMPACT FACTOR: 7.98 (INTERNATIONAL JOURNAL) Vol. 05, Special Issue 05, (ICET-2020)July 2020 Available Online: www.ajeee.co.in/index.php/AJEEE

61

SYNTHESIS AND CHARACTERIZATION OF PHARMACEUTICAL INTERMEDIATES

1Solanke Sumit Rajebhau, ²Dr. Yogesh Pralhadrao Patil

1Research Scholar, ²Supervisor

1-2 Department of Chemistry, Arunodaya University, Distt, Itanagar, Arunachal Pradesh, India

Abstract- The synthesis and characterization of pharmaceutical intermediates play a crucial role in the development of drugs and pharmaceutical products. This process involves the design and optimization of synthetic routes to produce key intermediate compounds, as well as the characterization and analysis of these intermediates to ensure their quality and purity. In this paper, we discuss various synthetic methods employed for the synthesis of pharmaceutical intermediates, including the key reactions and transformations involved. We also explore different characterization techniques, such as spectroscopic methods and analytical techniques, that are used for the identification and structural analysis of these intermediates. Understanding the synthesis and characterization of pharmaceutical intermediates is essential for the efficient and successful development of new drugs and pharmaceuticals.

Keywords: Synthesis, Characterization, Pharmaceutical intermediates, Synthetic methods, Key reactions, Transformations, Characterization techniques, Spectroscopic methods, Analytical techniques, Structural analysis, Drug development, Pharmaceutical products.

1 INTRODUCTION

The synthesis and characterization of pharmaceutical intermediates are fundamental steps in the development of drugs and pharmaceutical products. Pharmaceutical intermediates are key compounds that serve as building blocks or precursors in the synthesis of the final active pharmaceutical ingredients (APIs) or drug substances. These intermediates undergo various chemical reactions and transformations to achieve the desired molecular structure and functionality.

The synthesis of pharmaceutical intermediates involves the design and optimization of synthetic routes. Researchers employ different strategies and techniques to efficiently and selectively produce intermediates in a controlled manner. Synthetic methods such as organic synthesis, catalysis, and biocatalysis are utilized to access the target intermediate compounds. The choice of synthetic methodology depends on factors such as reactivity, selectivity, yield, and scalability.

Once synthesized, pharmaceutical intermediates need to be thoroughly characterized and analyzed to ensure their quality, purity, and structural integrity.

Characterization techniques play a crucial role in confirming the identity, assessing the purity, and determining the structure of these intermediates. Spectroscopic methods such as nuclear magnetic resonance (NMR), infrared (IR) spectroscopy, and mass spectrometry provide valuable information about the chemical composition and structural features of the intermediates. Additionally, various analytical techniques and separation methods, such as chromatography, are employed to analyze and quantify impurities or by-products.

Understanding the synthesis and characterization of pharmaceutical intermediates is essential for the successful development of new drugs and pharmaceutical products. It enables researchers to optimize synthetic processes, enhance product quality, and ensure the safety and efficacy of the final drug substances. In this paper, we will delve into the synthetic methods used for the synthesis of pharmaceutical intermediates, including the key reactions and transformations involved. We will also explore different characterization techniques and analytical methods employed to analyze and confirm the identity and quality of these intermediates. By gaining a comprehensive understanding of these aspects, researchers can contribute to the advancement of drug development and the production of high-quality pharmaceuticals.

1.1 Synthetic Methods:

In the synthesis of pharmaceutical intermediates, various synthetic methods are employed to efficiently and selectively produce the desired compounds. These methods involve the manipulation of chemical reactions and transformations to achieve the desired molecular

(2)

62

structure and functionality. Here are some commonly used synthetic methods in the development of pharmaceutical intermediates:

1.2 Organic Synthesis:

Organic synthesis is the foundation of pharmaceutical chemistry and involves the construction of complex organic molecules through well-defined reactions. It utilizes a wide range of synthetic techniques, including functional group transformations, protecting group strategies, and multi-step synthetic sequences. Organic synthesis provides flexibility in designing synthetic routes and enables the incorporation of specific functional groups required for the target intermediate compound.

1.3 Catalysis:

Catalysis plays a vital role in synthetic chemistry, including the synthesis of pharmaceutical intermediates. It involves the use of catalysts, which are substances that facilitate chemical reactions by lowering the activation energy, increasing reaction rates, and enhancing selectivity. Catalytic methods, such as transition metal catalysis, organocatalysis, and enzymatic catalysis, offer efficient and sustainable approaches for the synthesis of intermediates with high yields and selectivity.

1.4 Biocatalysis:

Biocatalysis involves the use of enzymes or whole cells as catalysts in chemical transformations. It offers several advantages in the synthesis of pharmaceutical intermediates, including high chemo-, regio-, and stereoselectivity. Enzymes can catalyze complex reactions under mild conditions and often exhibit high substrate specificity.

Biocatalysis enables the synthesis of chiral intermediates and can be used to perform reactions that are challenging using traditional chemical methods.

1.5 Synthetic Transformations:

Various synthetic transformations are employed in the synthesis of pharmaceutical intermediates. These transformations include functional group interconversions, such as oxidation, reduction, alkylation, acylation, and esterification. Protecting group chemistry is often utilized to selectively protect specific functional groups and control the reactivity of the molecule during subsequent reactions. Other transformations, such as cyclization, ring- opening reactions, and rearrangements, are employed to construct complex ring systems and introduce structural diversity.

1.6 Green Chemistry:

With growing emphasis on sustainable practices, green chemistry principles are increasingly applied in the synthesis of pharmaceutical intermediates. Green chemistry focuses on minimizing waste, reducing energy consumption, and using environmentally friendly solvents and reagents. It involves the development of efficient and atom-economical synthetic routes, recycling strategies, and the use of renewable starting materials.

By employing these synthetic methods, researchers can design efficient routes for the synthesis of pharmaceutical intermediates, optimizing reaction conditions, yields, and selectivity. These methods enable the production of high-quality intermediates that are essential for the development of safe and effective drugs.

1.7 Characterization Techniques:

Characterization techniques play a critical role in the analysis and confirmation of the identity, quality, and structural properties of pharmaceutical intermediates. These techniques provide valuable information about the chemical composition, purity, and structural features of the intermediates. Here are some commonly used characterization techniques in the field of pharmaceutical intermediate development:

1.8 Spectroscopic Methods:

a) Nuclear Magnetic Resonance (NMR): NMR spectroscopy is a powerful technique for structural analysis and identification of organic compounds. It provides information about the connectivity, stereochemistry, and chemical environment of atoms in a

(3)

63

molecule. Proton NMR (^1H-NMR) and carbon-13 NMR (^13C-NMR) are extensively used to characterize pharmaceutical intermediates.

b) Infrared Spectroscopy (IR): IR spectroscopy is employed to study the functional groups present in pharmaceutical intermediates. It provides information about the molecular vibrations, including stretching, bending, and combination bands of chemical bonds. IR spectra can be used for the identification and structural elucidation of intermediates.

c) Mass Spectrometry (MS): Mass spectrometry is a technique used for the determination of molecular weight and the identification of compounds. It involves ionizing molecules and separating them based on their mass-to-charge ratio. MS provides information about the molecular formula, fragmentation patterns, and structural information of pharmaceutical intermediates.

1.9 Chromatographic Techniques:

a) High-Performance Liquid Chromatography (HPLC): HPLC is widely used in the analysis of pharmaceutical intermediates. It separates compounds based on their differential partitioning between a stationary phase and a mobile phase. HPLC can provide quantitative analysis, purity assessment, and identification of intermediates.

b) Gas Chromatography (GC): GC is another chromatographic technique used for the separation and analysis of volatile compounds. It is commonly employed for the analysis of volatile impurities, residual solvents, and volatile intermediates in pharmaceutical development.

1.10 X-ray Crystallography:

X-ray crystallography is a powerful technique for determining the three-dimensional structure of pharmaceutical intermediates. It involves the crystallization of the compound and the analysis of X-ray diffraction patterns. This technique provides precise information about the bond lengths, bond angles, and molecular conformation of intermediates.

1.11 Thermal Analysis:

Thermal analysis techniques, such as Differential Scanning Calorimetry (DSC) and Thermogravimetric Analysis (TGA), are used to study the thermal properties of pharmaceutical intermediates. DSC measures the heat flow associated with endothermic and exothermic transitions, such as melting points and solid-state transformations. TGA provides information about the weight loss or gain as a function of temperature, indicating thermal stability, decomposition, or volatilization behavior.

1.12 Microscopy:

Microscopy techniques, including optical microscopy and electron microscopy, are used to examine the morphology and physical characteristics of pharmaceutical intermediates.

They provide information about particle size, shape, surface morphology, and crystal structure.

These characterization techniques, in combination with other analytical methods, enable researchers to confirm the identity, assess the quality, and determine the structural properties of pharmaceutical intermediates. They play a crucial role in ensuring the consistency and integrity of intermediates during drug development and manufacturing processes.

2 CONCLUSION

The synthesis and characterization of pharmaceutical intermediates are essential steps in the development of drugs and pharmaceutical products. Synthetic methods provide the means to efficiently and selectively produce these intermediates, utilizing organic synthesis, catalysis, biocatalysis, and various synthetic transformations. These methods enable researchers to design optimal synthetic routes and incorporate specific functional groups required for the target compounds.

Characterization techniques play a crucial role in confirming the identity, quality, and structural properties of pharmaceutical intermediates. Spectroscopic methods, such as NMR, IR, and mass spectrometry, provide valuable information about the chemical composition and structural features of intermediates. Chromatographic techniques,

(4)

64

including HPLC and GC, are employed for quantitative analysis, purity assessment, and identification. X-ray crystallography determines the three-dimensional structure of intermediates, while thermal analysis and microscopy techniques examine their thermal and physical properties.

Understanding and employing these synthetic and characterization methods are vital for the successful development of new drugs and pharmaceutical products. They ensure the consistency, quality, and safety of intermediates, leading to the production of high-quality drug substances. Additionally, the application of green chemistry principles promotes sustainability in pharmaceutical intermediate synthesis.

Advancements in synthetic methods and characterization techniques contribute to the advancement of drug development, enabling researchers to optimize processes, enhance product quality, and ensure the safety and efficacy of pharmaceuticals.

In conclusion, the synthesis and characterization of pharmaceutical intermediates are intricate processes that require expertise, precision, and comprehensive analysis. By utilizing the appropriate synthetic methods and employing a range of characterization techniques, researchers can contribute to the development of innovative drugs and the improvement of pharmaceutical manufacturing practices.

REFERENCES

1. Giuseppe Festa “Envisioning the challenges of the pharmaceutical sector in the Indian health-care industry: a scenario analysis”, Journal of Business & Industrial Marketing 37/8 (2022) 1662–1674 Emerald Publishing Limited [ISSN 0885-8624] [DOI 10.1108/JBIM-07-2020-0365] https://www.emerald.com/insight/0885- 8624.htm

2. Sandisiwe Maposa “Cytotoxicity Evaluation of Moringa Oleifera (M. Oleifera) Lam. Flowers on Human Liver Cancer Cell Line And A. Salina (Brine Shrimp) Models”, IJPSR, 2022; Vol. 13(12): 4909-4917. E-ISSN: 0975- 8232; P-ISSN: 2320- 5148 International Journal of Pharmaceutical Sciences and Research 4909 IJPSR (2022), Volume 13, Issue 12 DOI: 10.13040/IJPSR.0975-8232.13(12).4909-17 DOI link:

http://dx.doi.org/10.13040/IJPSR.0975-8232.13(12).4909-17

3. Akshata S. Menasinakai “Divalent Metal Complex of Coumarin: Synthesis & Cytotoxic Evaluation”, IJPSR, 2022; Vol. 13(12): 4918-4927. E-ISSN: 0975-8232; PISSN: 2320-5148 International Journal of Pharmaceutical Sciences and Research 4918 IJPSR (2022), Volume 13, Issue 12 DOI: 10.13040/IJPSR.0975- 8232.13(12).4918-27

4. Anil Kalotra “Marketing Strategies Of Different Pharmaceutical Companies”, Journal of Drug Delivery &

JDDTAO Available online at http://jddtonline.info

5. Shastri Bhawan “"Strengthening of Pharmaceuticals Industry (SPI)”, No. G30015/25/2021-Scheme Government of India Ministry of Chemicals & Fertilizers Department of Pharmaceuticals Dated the 11th March, 2022